TD Ameritrade Investment Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7
Closed -$2K 589
2023
Q1
$2K Sell
7
-1
-13% -$296 ﹤0.01% 499
2022
Q4
$2K Sell
8
-17
-68% -$4.69K ﹤0.01% 509
2022
Q3
$6K Sell
25
-27
-52% -$6.76K ﹤0.01% 416
2022
Q2
$11K Hold
52
﹤0.01% 427
2022
Q1
$14K Buy
52
+3
+6% +$736 ﹤0.01% 458
2021
Q4
$13K Buy
49
+41
+513% +$11.9K ﹤0.01% 460
2021
Q3
$2K Sell
8
-15
-65% -$4.28K ﹤0.01% 587
2021
Q2
$6K Buy
23
+16
+229% +$4.35K ﹤0.01% 516
2021
Q1
$2K Hold
7
﹤0.01% 588
2020
Q4
$2K Sell
7
-1
-13% -$248 ﹤0.01% 588
2020
Q3
$2K Hold
8
﹤0.01% 587
2020
Q2
$2K Buy
8
+5
+167% +$956 ﹤0.01% 580
2020
Q1
$0 Buy
+3
New +$548 ﹤0.01% 647

Other funds holding PODD

TD Ameritrade Investment Management's PODD Position: Q2 2023 in Review

TD Ameritrade Investment Management sold out of Insulet (PODD) in Q2 2023, closing a stake of 7 shares — an estimated $2K sold.

TD Ameritrade Investment Management first reported a position in PODD in Q1 2020 and held it in 13 quarters. The position peaked at $14K in Q1 2022. 578 funds tracked by Wall St. Rank hold PODD as of Q2 2023.

  • TD Ameritrade Investment Management reported no remaining Insulet position as of Q2 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 7 Insulet shares in Q2 2023, an estimated $2K.
  • TD Ameritrade Investment Management first reported a position in Insulet in Q1 2020 and held it in 13 quarters.
  • TD Ameritrade Investment Management's Insulet position peaked at $14K in Q1 2022.
  • 578 funds tracked by Wall St. Rank held Insulet as of Q2 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.